ARTICLE | Company News
Compendia Bioscience, H3 Biomedicine deal
February 20, 2012 8:00 AM UTC
Compendia and H3 Biomedicine will use Compendia's suite of Oncomine tools to mine data from The Cancer Genome Atlas (TCGA) at NIH to discover therapeutic targets and biomarkers to support drug develop...